JPMorgan Chase & Co’s HilleVax HLVX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $5.17K | Sell |
2,598
-45,418
| -95% | -$90.4K | ﹤0.01% | 5533 |
|
|
2025
Q1 | $69.6K | Sell |
48,016
-159,135
| -77% | -$231K | ﹤0.01% | 4911 |
|
|
2024
Q4 | $429K | Buy |
207,151
+193,124
| +1,377% | +$400K | ﹤0.01% | 4220 |
|
|
2024
Q3 | $24.7K | Sell |
14,027
-19,375
| -58% | -$34.1K | ﹤0.01% | 5168 |
|
|
2024
Q2 | $483K | Sell |
33,402
-13,670
| -29% | -$198K | ﹤0.01% | 3877 |
|
|
2024
Q1 | $783K | Buy |
47,072
+29,730
| +171% | +$494K | ﹤0.01% | 3707 |
|
|
2023
Q4 | $278K | Sell |
17,342
-4,606
| -21% | -$73.9K | ﹤0.01% | 4225 |
|
|
2023
Q3 | $295K | Buy |
21,948
+4,229
| +24% | +$56.9K | ﹤0.01% | 3999 |
|
|
2023
Q2 | $305K | Buy |
17,719
+2,810
| +19% | +$48.3K | ﹤0.01% | 4044 |
|
|
2023
Q1 | $246K | Buy |
14,909
+3,561
| +31% | +$58.8K | ﹤0.01% | 4213 |
|
|
2022
Q4 | $190K | Buy |
11,348
+4,266
| +60% | +$71.4K | ﹤0.01% | 4226 |
|
|
2022
Q3 | $121K | Buy |
7,082
+153
| +2% | +$2.61K | ﹤0.01% | 4389 |
|
|
2022
Q2 | $76K | Buy |
+6,929
| New | +$76K | ﹤0.01% | 4735 |
|